Why compare pollen immunotherapy options now

Pollen seasons are longer and more intense than in past decades, increasing the number of people affected and the severity of symptoms. Up to 60 million people in the U.S. experience allergic rhinitis annually, and climate trends are extending pollen seasons and raising concentrations. Choosing the right immunotherapy matters for effectiveness, safety, convenience, and cost.

What each option is (and treats)

• Allergy shots (SCIT)

• What it is: Subcutaneous injections in a clinic that gradually increase allergen dose to build tolerance.

• Typical course: Weekly build‑up for months, then maintenance every 2–4 weeks; total 3–5 years.

• Treats: Most inhalant pollens (grasses, weeds like ragweed, trees) and can combine multiple allergens in one plan.

• SLIT tablets (FDA‑approved tablets under the tongue)

• What it is: Daily tablets taken at home for a single allergen (e.g., certain grasses, ragweed, or dust mite), prescribed by a clinician.

• Typical course: Daily dosing for 3 years around (and often beyond) the relevant season; initial dose usually given under supervision.

• Treats: Specific pollens (selected grasses), ragweed, and dust mite—one tablet per allergen.

• SLIT drops (custom “allergy drops” under the tongue)

• What it is: Daily drops compounded from FDA‑approved extracts to desensitize at home; off‑label in the U.S. but guideline‑supported and widely used.

• Typical course: Daily dosing 3–5 years; physician‑supervised telehealth or in‑practice follow‑up.

• Treats: Multiple pollens (grasses/trees/weeds) and other environmental allergens in one plan.

Effectiveness (long‑term desensitization)

• High‑quality reviews and practice guidelines support both SCIT and SLIT as effective for long‑term symptom reduction; neither clearly outperforms the other in head‑to‑head evidence.

• Typical response rates reported by medical groups/practices are on the order of ~70–85% for allergic rhinitis when patients complete therapy.

Safety profile

• SCIT: Effective but requires clinic monitoring for 30 minutes after injections due to rare risk of systemic reactions/anaphylaxis.

• SLIT tablets/drops: Very favorable safety profile; most reactions are mild (oral itching, throat irritation). Severe reactions are exceedingly rare, and no deaths have been reported with SLIT drops in the literature summarized here.

Time to improvement and duration

• First improvements

• SCIT: Often 6–12 months.

• SLIT tablets: ~3–4 months is typical to notice benefit.

• SLIT drops: Many patients 4 weeks–6 months.

• Course length for durable benefit: 3–5 years for all three modalities.

Access, convenience, and cost considerations

• Visit burden

• SCIT: Weekly in‑office injections during build‑up; then monthly.

• SLIT tablets & drops: 100% at‑home after first dose (tablets) or from the start (drops).

• Multi‑allergen treatment

• SCIT: Yes, commonly combined.

• SLIT tablets: One allergen per tablet (e.g., grass OR ragweed).

• SLIT drops: Multi‑allergen formulations possible.

• Insurance and out‑of‑pocket

• SCIT: Often covered; without coverage, total costs can reach $1,600–$4,000/year (medication + visit administration), varying by plan and region.

• SLIT tablets: Prescription benefit varies by plan; each tablet treats one allergen.

• SLIT drops: Typically not insurance‑covered in the U.S.; many practices offer transparent subscriptions (e.g., $99/month at Wyndly).

When to choose each (decision guide)

Scenario	Best fit	Why	Notes
You want broad coverage for several pollens at once and don’t mind clinic visits	SCIT or SLIT drops	Both can target multiple allergens in one plan	SCIT usually insurance‑covered; requires office time and monitoring
You only need a single, FDA‑approved allergen (e.g., Timothy/grass mix, ragweed) and prefer a labeled option	SLIT tablets	Strong evidence, at‑home dosing, labeled for specific allergens	One tablet per allergen; initial dose often supervised
You need at‑home, needle‑free care and have multiple pollen triggers	SLIT drops	Convenient multi‑allergen at home; favorable safety	Off‑label in U.S. but guideline‑supported; typically cash‑pay
You have a history of severe reactions to injections or limited clinic access	SLIT tablets or drops	Lower severe reaction risk; no injection visits	Discuss with your physician if you carry epinephrine or have uncontrolled asthma
You prioritize the lowest out‑of‑pocket with insurance	SCIT (if covered)	Many plans cover shots and clinic administration	Verify copays/deductibles; travel/time costs still apply

Clinical caveats and eligibility

• All three approaches are disease‑modifying; choice should be guided by your allergy profile, medical history (including asthma control), and lifestyle.

• SLIT (drops/tablets) is generally appropriate for ages 5+; avoid SLIT if you are pregnant, on certain beta blockers, or have specific conditions such as eosinophilic esophagitis (EoE) or mast cell activation syndrome (MCAS).

• Wyndly (telehealth) treats environmental—not food—allergies.

If you choose an at‑home SLIT path

A typical at‑home flow includes identifying triggers (at‑home IgE test), meeting a board‑certified physician online, and starting a personalized SLIT plan with regular follow‑ups. Wyndly offers this for $99/month after consult, with multi‑allergen drops, 24/7 support, and a 90‑day money‑back guarantee if you don’t improve.

Frequently asked questions

• Are SLIT drops FDA‑approved?

• In the U.S., specific SLIT tablets are FDA‑approved for a few allergens (certain grasses, ragweed, dust mite). Custom SLIT drops use FDA‑approved extracts and are prescribed off‑label with evidence and guideline support.

• How safe is SLIT compared to shots?

• SLIT’s severe reaction risk is extremely low; shots require in‑office monitoring due to rare anaphylaxis.

• When will I feel better?

• Tablets: ~3–4 months; Drops: 4 weeks–6 months; Shots: often 6–12 months. Full courses are 3–5 years for durable tolerance.

• Can tablets or drops treat multiple allergens at once?

• Tablets treat one allergen per product; drops and shots can address multiple concurrent pollens.

• Do I have to stop my antihistamines before testing or treatment?

• Blood‑based IgE tests generally do not require stopping antihistamines; your physician will advise. During immunotherapy, many patients taper symptom meds as control improves.

• Is immunotherapy right for kids?

• Yes, many programs treat ages 5+; discuss pediatric specifics and asthma control with your clinician.

References and further reading

• CDC: Allergens and pollen and climate impacts.

• Allergy prevalence and immunotherapy outcomes.

• How allergy shots work, timelines, in‑office monitoring.

• Evidence and guidance for SLIT tablets and drops.

• Safety data and anaphylaxis comparison.

• Cost context for shots vs at‑home options.